Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The challenge of chronic inflammation surrounding medical implants is a persistent hurdle in achieving optimal patient outcomes. NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of developing advanced biomaterials designed to actively manage and mitigate these inflammatory responses. Our cutting-edge research, particularly involving catalase nanocapsules for osteogenesis, offers a promising solution for improving implant integration in chronic inflammation.
When implants are introduced into the body, the immune system's response can sometimes lead to prolonged inflammation. This chronic inflammatory state can release harmful reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), which impair cellular function, including the osteoblasts responsible for bone formation. Consequently, this can lead to poor osseointegration and implant failure. NINGBO INNO PHARMCHEM CO.,LTD. recognized this critical need and focused its research on developing materials that can actively counter these effects.
Our innovative approach utilizes catalase, an enzyme that efficiently neutralizes H2O2. By encapsulating catalase within protective nanostructures, we ensure its stability and controlled release directly at the implant site. This targeted action allows the catalase to break down the damaging ROS, thereby reducing inflammation and creating a more conducive environment for bone regeneration. This is a key component of our advanced chitosan gel coating for titanium implants.
Furthermore, this anti-inflammatory strategy works synergistically with other beneficial properties. For instance, the incorporation of silver nanoparticles for antimicrobial effect provides a robust defense against bacterial infections, another common complication that can exacerbate inflammation. This multi-faceted approach ensures that our titanium alloy surface modification for implants addresses both infectious and inflammatory challenges simultaneously.
The development of materials that actively manage inflammation marks a significant advancement in implantology. NINGBO INNO PHARMCHEM CO.,LTD. is proud to be leading this charge, offering solutions that not only improve the mechanical performance of implants but also enhance their biological compatibility and healing potential. Our continued dedication to research ensures that we provide the most effective and reliable biomaterials for a healthier future.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
